CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
CorEvitas
Summary
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Description
The objective of the registry is to create a cohort of AA subjects to study long-term safety and effectiveness of AA treatments. Because the long-term understanding of safety and efficacy is still limited even after regulatory approval,enrollment and long-term follow-up of a large number of diverse real-world patients exposed to therapies of interest is important to understand safety and effectiveness. The observational structured data collected will be used to better characterize the natural history of the disease and to extensively evaluate the effectiveness and safety of medications approve…
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- Not specified
Inclusion Criteria: * A subject must meet all the following criteria to participate in the registry: 1. Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner. 2. Is at least 18 years of age or older. 3. Is willing to provide Personal Information. 4. Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment. Exclusion Criteria: * Any of the following would exclude the subject from participating in the registry: 1. Is participating or planning to participate in a double-blind randomized trial for an AA drug.…
Location
- CorEvitas, LLCWaltham, Massachusetts